Logo image of DYA.CA

DYNACERT INC (DYA.CA) Stock Fundamental Analysis

Canada - TSX:DYA - CA26780A1084 - Common Stock

0.14 CAD
0 (-3.45%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DYA. DYA was compared to 15 industry peers in the Electrical Equipment industry. DYA has a bad profitability rating. Also its financial health evaluation is rather negative. DYA has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year DYA has reported negative net income.
DYA had a negative operating cash flow in the past year.
In the past 5 years DYA always reported negative net income.
DYA had a negative operating cash flow in each of the past 5 years.
DYA.CA Yearly Net Income VS EBIT VS OCF VS FCFDYA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

DYA has a worse Return On Assets (-242.21%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA -242.21%
ROE N/A
ROIC N/A
ROA(3y)-201.12%
ROA(5y)-150.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DYA.CA Yearly ROA, ROE, ROICDYA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DYA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DYA.CA Yearly Profit, Operating, Gross MarginsDYA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

More info and screens

0

2. Health

2.1 Basic Checks

DYA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DYA has more shares outstanding
Compared to 5 years ago, DYA has more shares outstanding
Compared to 1 year ago, DYA has a worse debt to assets ratio.
DYA.CA Yearly Shares OutstandingDYA.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
DYA.CA Yearly Total Debt VS Total AssetsDYA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

DYA has an Altman-Z score of -31.56. This is a bad value and indicates that DYA is not financially healthy and even has some risk of bankruptcy.
DYA's Altman-Z score of -31.56 is on the low side compared to the rest of the industry. DYA is outperformed by 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -31.56
ROIC/WACCN/A
WACC7.96%
DYA.CA Yearly LT Debt VS Equity VS FCFDYA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

DYA has a Current Ratio of 0.51. This is a bad value and indicates that DYA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of DYA (0.51) is worse than 66.67% of its industry peers.
DYA has a Quick Ratio of 0.51. This is a bad value and indicates that DYA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DYA (0.24) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.51
Quick Ratio 0.24
DYA.CA Yearly Current Assets VS Current LiabilitesDYA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for DYA have decreased strongly by -58.64% in the last year.
Looking at the last year, DYA shows a quite strong growth in Revenue. The Revenue has grown by 15.18% in the last year.
DYA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.61% yearly.
EPS 1Y (TTM)-58.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.87%
Revenue 1Y (TTM)15.18%
Revenue growth 3Y28.22%
Revenue growth 5Y8.61%
Sales Q2Q%-92.89%

3.2 Future

DYA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.65% yearly.
DYA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 263.86% yearly.
EPS Next Y100%
EPS Next 2Y55.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year656.55%
Revenue Next 2Y263.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DYA.CA Yearly Revenue VS EstimatesDYA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
DYA.CA Yearly EPS VS EstimatesDYA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2026 0 -0.02 -0.04

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DYA. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 13.86, which indicates a correct valuation of DYA.
DYA's Price/Forward Earnings ratio is rather cheap when compared to the industry. DYA is cheaper than 86.67% of the companies in the same industry.
DYA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.85.
Industry RankSector Rank
PE N/A
Fwd PE 13.86
DYA.CA Price Earnings VS Forward Price EarningsDYA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DYA.CA Per share dataDYA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 -0.02

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as DYA's earnings are expected to grow with 55.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.65%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DYA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DYNACERT INC

TSX:DYA (10/16/2025, 7:00:00 PM)

0.14

0 (-3.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-13 2025-08-13
Earnings (Next)11-12 2025-11-12
Inst Owners3.62%
Inst Owner ChangeN/A
Ins Owners6.51%
Ins Owner ChangeN/A
Market Cap71.16M
Analysts84
Price Target0.77 (450%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.86
P/S 60.74
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)0.01
Fwd EY7.21%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -242.21%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-201.12%
ROA(5y)-150.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.34%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.51
Quick Ratio 0.24
Altman-Z -31.56
F-Score3
WACC7.96%
ROIC/WACCN/A
Cap/Depr(3y)6.19%
Cap/Depr(5y)101.41%
Cap/Sales(3y)7.56%
Cap/Sales(5y)101.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.87%
EPS Next Y100%
EPS Next 2Y55.65%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.18%
Revenue growth 3Y28.22%
Revenue growth 5Y8.61%
Sales Q2Q%-92.89%
Revenue Next Year656.55%
Revenue Next 2Y263.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year117.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43.95%
OCF growth 3YN/A
OCF growth 5YN/A